It's not just a case of poker face for pharmaceuticals

Davis, Nigel; Gibson, Jane
February 2007
ICIS Chemical Business;2/26/2007, Vol. 2 Issue 55, p17
Trade Publication
The article examines the decision of Belgium-based Solvay, a producer of vinyls and vinyl products, soda ash, specialties and pharmaceuticals, to focus more on the latter rather than commodities. The company revealed lower than expected fourth-quarter financial results in February 2007. The author believes that growing the pharmaceutical business of Solvay is essential but not to the detriment of its drive into specialties and new geographical areas.


Related Articles

  • Solvay bucks trend and focuses on pharma.  // Life Science Today;Apr2001, Vol. 2 Issue 2, p6 

    Reports on Belgian chemicals and pharmaceutical group Solvay's plan to accelerate the development of its pharmaceutical sector. Move going against the trend of major chemical groups' withdrawal from pharmaceuticals; Financial performance of the company in 2000.

  • Solvay invests €120m in China plant. JAGGER, ANNA // ICIS Chemical Business;7/4/2011, Vol. 280 Issue 1, p28 

    The article offers information on the business plans of Solvay SA to invest 170 million dollars in a specialty polymers plant at its Changshu site in China.

  • Sovay Forms a New Pharma Unit; Combines Plastics Divisions. Alperowicz, Natasha // Chemical Week;4/7/2004, Vol. 166 Issue 12, p16 

    Looks at the reorganization plans of Solvay SA on its business operations in 2004. Aim of company plans to combine its pharmaceutical businesses into a new company; Sales performance of Solvay's pharmaceutical division in 2003; Consolidation plans on its plastics and plastics processing businesses.

  • The All New FMCG Juniors. Shukla, Archna // Business Today;1/28/2007, Vol. 16 Issue 2, p76 

    The article discusses the success of fast-moving consumer goods company Paras Pharmaceuticals in India. Paras acquires manufacturing facilities abroad, breaks open consumer markets outside the country and plans to have more launches at their unbeatable price points. Their success can be credited...

  • Company Spotlight: Procter & Gamble.  // MarketWatch: Global Round-up;Jan2007, Vol. 6 Issue 1, p91 

    The article focuses on Procter & Gamble, a global manufacturer and marketer of consumer products. The company plans to resume sales of its prestige SK-II skincare products. Procter & Gamble owns and operates 35 manufacturing facilities and leases and operates two manufacturing facilities in the...

  • EUROPE IN BRIEF.  // Life Science Today;Apr2001, Vol. 2 Issue 2, p6 

    Reports on developments in the pharmaceutical industry in Europe for the period ended April 2001. Solvay's refocus of its research and development efforts; Increase in drug prices in Hungary effective July 1, 2001.

  • Solvay's first-quarter net income up 44% YOY.  // Chemical Week;5/4/2015, Vol. 177 Issue 13, p5 

    The article reports on the 44% year-on-year growth of the net adjusted income of chemicals company Solvay SA in the first quarter of 2015.

  • Solvay Casting Net for Pharma Partner.  // Chemical Market Reporter;4/5/2004, Vol. 265 Issue 14, p6 

    Reports on the decision of Solvay to transfer its pharmaceuticals unit into a separate company in Europe.

  • Solvay Group SWOT Analysis.  // Solvay Group SWOT Analysis;December 2003, p1 

    Presents an overview of Solvay Group SA, which is an international chemical and pharmaceutical company, and its four sectors of activity specifically being chemicals, pharmaceuticals, plastics and processing. Company overview, including revenues generated in fiscal year 2002 and location of its...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics